To examine the relation between serum ascorbic acid level and the prev
alence of cardiovascular disease, we analyzed data from 6,624 U.S, men
and women enrolled in the Second National Health and Nutrition Examin
ation Sun-ep. We calculated odds ratios and 95% confidence intervals t
o estimate the relative prevalence. of cardiovascular disease, defined
as self-reported coronary heart disease or stroke, or a diagnosis of
peripheral vascular disease based on physical examination. Serum ascor
bic acid levels were independently associated with prevalence of coron
ary heart disease and stroke; a 0.5-mg per dl increase in serum ascorb
ic acid level was associated with an 11% reduction in coronary heart d
isease and stroke prevalence. We also analyzed the relation of ascorbi
c acid, grouped into low to marginal, normal, and saturation serum cat
egories, to cardiovascular disease. Compared with participants with lo
w to marginally low serum ascorbic acid levels, we found a 27% decreas
ed prevalence of coronary heart disease (95% confidence interval = 10-
41%) and a 26% decreased prevalence of stroke (95% confidence interval
= 3-44%) among participants in the highest serum ascorbic acid catego
ry. Serum ascorbic acid levels were not consistently associated with p
revalence of peripheral vascular disease. These results are consistent
with the hypothesis that increased ascorbic acid intake may decrease
the risk of coronary heart disease and stroke.